Pancreatic Cancer Research

ResearcherYamaguchi UniversityNo recent work listed

Keiko Shibuya

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1581-3253; OpenAlex author ID A5102706990. Sources: OpenAlex.

Their work

Papers
11 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
23
Papers, trials and grants by year

2011: 1 paper · 2012: 4 papers · 2013: 2 papers · 2014: 1 paper · 2015: 1 paper · 2016: none · 2017: 1 paper · 2018: 1 paper

Papers 11

  1. Clinical evaluation of intensity-modulated radiotherapy for locally advanced pancreatic cancer. Co-author DOI 10.1186/s13014-018-1063-5↗
  2. A Prospective Study of Intensity-modified Radiation Therapy in Comparison with Conventional 3D-RT for BR Pancreatic Cancer Patients with Arterial Involvement. Co-author DOI 10.21873/anticanres.12172↗
  3. Pretreatment C-reactive protein level predicts outcome and patterns of failure after chemoradiotherapy for locally advanced pancreatic cancer. Co-author DOI 10.1016/j.pan.2015.09.016↗
  4. Radiotherapy for patients with isolated local recurrence of primary resected pancreatic cancer. Prolonged disease-free interval associated with favorable progn… Co-author DOI 10.1007/s00066-014-0610-8↗
  5. Interfractional dose variations in the stomach and the bowels during breathhold intensity-modulated radiotherapy for pancreatic cancer: Implications for a dose… First author DOI 10.1118/1.4773033↗
  6. Effects of interportal error on dose distribution in patients undergoing breath-holding intensity-modulated radiotherapy for pancreatic cancer: evaluation of a… Co-author DOI 10.1120/jacmp.v14i5.4252↗
  7. Interfractional dose variations in intensity-modulated radiotherapy with breath-hold for pancreatic cancer. First author DOI 10.1016/j.ijrobp.2011.01.050↗
  8. Concurrent radiotherapy and gemcitabine for unresectable pancreatic adenocarcinoma: impact of adjuvant chemotherapy on survival. Co-author DOI 10.1016/j.ijrobp.2011.07.013↗
  9. Analysis of dosimetric parameters associated with acute gastrointestinal toxicity and upper gastrointestinal bleeding in locally advanced pancreatic cancer pat… First author DOI 10.1016/j.ijrobp.2011.12.026↗
  10. Dosimetric investigation of breath-hold intensity-modulated radiotherapy for pancreatic cancer. Co-author DOI 10.1118/1.3668314↗
  11. Phase II study of radiation therapy combined with weekly low-dose gemcitabine for locally advanced, unresectable pancreatic cancer. Co-author DOI 10.1097/coc.0b013e3181c4c7a8↗

Closest collaborators

The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Masahiro Hiraoka · 9 shared papers, 2011–2018 · strength 0.36
  2. Takashi Mizowaki · 6 shared papers, 2012–2018 · strength 0.26
  3. Akira Nakamura · 7 shared papers, 2012–2015 · strength 0.26
  4. Kyoichi Takaori · 4 shared papers, 2014–2018 · strength 0.21
  5. Masashi Kanai · 3 shared papers, 2015–2018 · strength 0.17
  6. Mitsuhiro Nakamura · 5 shared papers, 2012–2013 · strength 0.17
  7. Toshihiko Masui · 2 shared papers, 2017–2018 · strength 0.13
  8. Yökö Gotö · 2 shared papers, 2017–2018 · strength 0.13
  9. Yuzo Kodama · 2 shared papers, 2017–2018 · strength 0.13
  10. Akira Nakamura · 2 shared papers, 2011–2018 · strength 0.10
  11. Shinji Üemoto · 2 shared papers, 2014–2017 · strength 0.10
  12. Ryo Ashida · 1 shared paper, 2018 · strength 0.07
  13. Asahi Sato · 1 shared paper, 2017 · strength 0.06
  14. Yuichiro Uchida · 1 shared paper, 2017 · strength 0.06
  15. Takahiro Kishi · 1 shared paper, 2015 · strength 0.05
  16. Yuzo Kodama · 1 shared paper, 2015 · strength 0.05
  17. Michio Yoshimura · 1 shared paper, 2014 · strength 0.04
  18. Teruki Teshima · 1 shared paper, 2013 · strength 0.03
  19. Toru Takakura · 1 shared paper, 2013 · strength 0.03
  20. Kazuhiko Ogawa · 1 shared paper, 2012 · strength 0.03
  21. Hiroshi Onishi · 1 shared paper, 2012 · strength 0.03
  22. Katsuyuki Karasawa · 1 shared paper, 2012 · strength 0.03
  23. Yasumasa Nishimura Md · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.